Chris Collins sold Innate Immunotherapeutics (--)
Chris Collins (R-NY), a U.S. Representative, has disclosed 40 trades in Innate Immunotherapeutics (--) since 2012, 16 purchases and 24 sales, worth an estimated $19M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Chris Collins sold $250,001 - $500,000 of Innate Immunotherapeutics (--) on June 25, 2018. Since that trade, -- is up +0.00% against the S&P 500 up +212.32%, an outperformance of -212.32%.
Across these filings, Chris Collins has been a net seller of -- (a buy-to-sell ratio of 0.67). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Chris Collins's -- trades vs the price
-- is up +0.00% since Chris Collins sold on June 25, 2018, versus +212.32% for the S&P 500.
Performance since this trade
All Chris Collins -- trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Chris Collins & -- trading FAQ
Is it legal for Chris Collins to trade Innate Immunotherapeutics (--) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Innate Immunotherapeutics (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Chris Collins sell --?
Chris Collins disclosed a sale of $250,001 - $500,000 of Innate Immunotherapeutics (--) on June 25, 2018, according to public STOCK Act filings.
How has -- performed since Chris Collins's trade?
Since Chris Collins sold -- on June 25, 2018, the stock is up +0.00%, versus +212.32% for the S&P 500 over the same period, an outperformance of -212.32%.
How many times has Chris Collins traded --?
Chris Collins has disclosed 40 -- trades since 2012 (16 purchases and 24 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional -- trades?
BullishWhales tracks every disclosed congressional trade in Innate Immunotherapeutics (--) on the Innate Immunotherapeutics congressional trading page, which aggregates filings across all members of Congress.
Chris Collins's -- tradesAll congressional filings for Innate ImmunotherapeuticsChris Collins's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.